206 related articles for article (PubMed ID: 18976926)
1. Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.
Guo XZ; Shi L; Wang R; Liu XX; Li BG; Lu XX
Bioorg Med Chem; 2008 Dec; 16(24):10301-10. PubMed ID: 18976926
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres.
Kohara Y; Kubo K; Imamiya E; Wada T; Inada Y; Naka T
J Med Chem; 1996 Dec; 39(26):5228-35. PubMed ID: 8978851
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
Yanagisawa H; Amemiya Y; Kanazaki T; Shimoji Y; Fujimoto K; Kitahara Y; Sada T; Mizuno M; Ikeda M; Miyamoto S; Furukawa Y; Koike H
J Med Chem; 1996 Jan; 39(1):323-38. PubMed ID: 8568823
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists.
Bali A; Bansal Y; Sugumaran M; Saggu JS; Balakumar P; Kaur G; Bansal G; Sharma A; Singh M
Bioorg Med Chem Lett; 2005 Sep; 15(17):3962-5. PubMed ID: 16039125
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.
Kaur N; Kaur A; Bansal Y; Shah DI; Bansal G; Singh M
Bioorg Med Chem; 2008 Dec; 16(24):10210-5. PubMed ID: 19013821
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.
Bai R; Wei Z; Liu J; Xie W; Yao H; Wu X; Jiang J; Wang Q; Xu J
Bioorg Med Chem; 2012 Aug; 20(15):4661-7. PubMed ID: 22750010
[TBL] [Abstract][Full Text] [Related]
11. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
Ries UJ; Mihm G; Narr B; Hasselbach KM; Wittneben H; Entzeroth M; van Meel JC; Wienen W; Hauel NH
J Med Chem; 1993 Dec; 36(25):4040-51. PubMed ID: 8258826
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.
Touzeau F; Arrault A; Guillaumet G; Scalbert E; Pfeiffer B; Rettori MC; Renard P; Mérour JY
J Med Chem; 2003 May; 46(10):1962-79. PubMed ID: 12723959
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activities of non-peptide angiotensin receptor antagonists with tetrazole replaced imidazole ring.
Wahhab A; Smith J; Moore GJ
Arzneimittelforschung; 1993 Aug; 43(8):828-30. PubMed ID: 8216436
[TBL] [Abstract][Full Text] [Related]
14. Potential antihypertensive benzimidazole derivatives.
Serafin B; Borkowska G; Główczyk J; Kowalska I; Rump S
Pol J Pharmacol Pharm; 1989; 41(1):89-96. PubMed ID: 2587441
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
Wexler RR; Greenlee WJ; Irvin JD; Goldberg MR; Prendergast K; Smith RD; Timmermans PB
J Med Chem; 1996 Feb; 39(3):625-56. PubMed ID: 8576904
[No Abstract] [Full Text] [Related]
16. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and pharmacological evaluation of novel NO-releasing benzimidazole hybrids as potential antihypertensive candidate.
Zhang Y; Xu J; Li Y; Yao H; Wu X
Chem Biol Drug Des; 2015 May; 85(5):541-8. PubMed ID: 25283264
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and antihypertensive activity of 2-phenyl substituted benzimidazoles.
Khan MT; Razi MT; Jan SU; Mukhtiar M; Gul R; IzharUllah -; Hussain A; Hashmi AM; Ahmad MT; Shahwani NA; Rabbani I
Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1067-1074. PubMed ID: 29731445
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series.
Rivara M; Zuliani V; Cocconcelli G; Morini G; Comini M; Rivara S; Mor M; Bordi F; Barocelli E; Ballabeni V; Bertoni S; Plazzi PV
Bioorg Med Chem; 2006 Mar; 14(5):1413-24. PubMed ID: 16263297
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis.
Hernández-Luis F; Hernández-Campos A; Castillo R; Navarrete-Vázquez G; Soria-Arteche O; Hernández-Hernández M; Yépez-Mulia L
Eur J Med Chem; 2010 Jul; 45(7):3135-41. PubMed ID: 20430484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
